{"id":"W3202978375","doi":"10.21037/jtd-21-804","title":"Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Public Health Ontario; University Health Network; University of Toronto; Princess Margaret Cancer Centre; William Osler Health System","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation; Cancer Care Ontario","keywords":"Erlotinib; Medicine; Hazard ratio; Internal medicine; Lung cancer; Erlotinib Hydrochloride; Cohort; Retrospective cohort study; Proportional hazards model; Oncology; Population; Cancer; Epidermal growth factor receptor; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001284082,0.0001204925,0.0003107057,0.0001283101,0.0000239008,0.00004327463,0.00003211774,0.00001930802,0.0001219609],"category_scores_gemma":[0.0001315377,0.00009583281,0.00003975922,0.0001408364,0.00001106693,0.0002882702,0.00003052008,0.0001887467,1.935028e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004878049,"about_ca_system_score_gemma":0.002250305,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1855172,"about_ca_topic_score_gemma":0.8267528,"domain_scores_codex":[0.9990591,0.0000748708,0.0003682603,0.0001501567,0.0001835168,0.0001641168],"domain_scores_gemma":[0.9989514,0.0002524041,0.000206941,0.0001152668,0.0001229173,0.000351064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005661304,0.0002382246,0.9906523,0.0004044864,0.0001178556,0.005355,0.0003048249,0.0001029414,0.00005746576,0.000001188607,0.000293271,0.001906374],"study_design_scores_gemma":[0.001980711,0.00003744183,0.9953014,0.0006747327,0.0006080374,0.00005816713,0.000387773,0.0002945469,0.0001321509,0.000006128968,0.0004272404,0.00009173107],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936746,0.002050353,0.000007027265,0.003534627,0.0001510057,0.0001823928,0.0001268374,0.000002080334,0.0002710492],"genre_scores_gemma":[0.9954495,0.000989886,0.0003799218,0.001217088,0.0000542365,0.000008015534,0.00001245959,0.00001480451,0.001874093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6412356,"threshold_uncertainty_score":0.8199065,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01734683266948331,"score_gpt":0.355977957216803,"score_spread":0.3386311245473197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}